1-16 of 16
Kathleen R. Cho
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B50: Direct interrogation of the incessant ovulation hypothesis in a high-fidelity mouse model of high-grade serous cancer

Yali Zhai, Kevin McCool, Rork Kuick, Lixing Chen, Eric R. Fearon, Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): B50.
https://doi.org/10.1158/1557-3265.OVCA19-B50
Published: 01 July 2020
View articletitled, Abstract B50: Direct interrogation of the incessant ovulation hypothesis in a high-fidelity mouse model of high-grade serous cancer
Journal Articles

Abstract B65: Defining the tumor immune landscape in a mouse model of high-grade serous carcinoma

Kevin W. McCool, Rork Kuick, Yali Zhai, Zach Freeman, Rong Wu, Eric Fearon, Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): B65.
https://doi.org/10.1158/1557-3265.OVCA19-B65
Published: 01 July 2020
View articletitled, Abstract B65: Defining the tumor immune landscape in a mouse model of high-grade serous carcinoma
Journal Articles

Abstract IA14: Integrated molecular characterization of the genome, transcriptome, and immune microenvironment in oviductal high-grade serous carcinomas arising in genetically engineered mice

Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): IA14.
https://doi.org/10.1158/1557-3265.OVCA19-IA14
Published: 01 July 2020
View articletitled, Abstract IA14: Integrated molecular characterization of the genome, transcriptome, and immune microenvironment in oviductal high-grade serous carcinomas arising in genetically engineered mice
Journal Articles

Abstract AP16: MODELING ENDOMETRIOID AND HIGH GRADE SEROUS CARCINOMAS IN THE MOUSE USING CRISPR/CAS9-MEDIATED SOMATIC GENE EDITING IN FALLOPIAN TUBE EPITHELIUM

Rong Wu, Carmine Stolfi, Yali Zhai, Eric R. Fearon, Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): AP16.
https://doi.org/10.1158/1557-3265.OVCASYMP18-AP16
Published: 15 November 2019
View articletitled, Abstract AP16: MODELING ENDOMETRIOID AND HIGH GRADE SEROUS CARCINOMAS IN THE MOUSE USING CRISPR/CAS9-MEDIATED SOMATIC GENE EDITING IN FALLOPIAN TUBE EPITHELIUM
Journal Articles

Abstract GMM-061: MOLECULAR CHARACTERIZATION OF MOUSE MODELS OF HIGH-GRADE SEROUS CARCINOMA ARISING IN THE OVIDUCT

Yali Zhai, Yisheng Wang, Stephanie M. Schulman, Kevin Hu, Albert Liu, Scott A. Tomlins, Eric R. Fearon, Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): GMM-061.
https://doi.org/10.1158/1557-3265.OVCASYMP18-GMM-061
Published: 15 November 2019
View articletitled, Abstract GMM-061: MOLECULAR CHARACTERIZATION OF MOUSE MODELS OF HIGH-GRADE SEROUS CARCINOMA ARISING IN THE OVIDUCT
Journal Articles

Abstract B76: Oncogenic Kras and Pik3ca can cooperate with inactivation of various tumor suppressor genes to generate high-grade serous carcinomas in the mouse oviduct

Yali Zhai, Stephanie Schulman, Neil Khandwala, Eric R. Fearon, Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15_Supplement): B76.
https://doi.org/10.1158/1557-3265.OVCA17-B76
Published: 01 August 2018
View articletitled, Abstract B76: Oncogenic Kras and Pik3ca can cooperate with inactivation of various tumor suppressor genes to generate high-grade serous carcinomas in the mouse oviduct
Journal Articles

Abstract TMEM-018: IN VITRO MODELS OF HGSC BASED ON MURINE OVIDUCTAL EPITHELIAL ORGANOIDS

Yali Zhai, Eric R. Fearon, Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): TMEM-018.
https://doi.org/10.1158/1557-3265.OVCASYMP16-TMEM-018
Published: 31 May 2017
View articletitled, Abstract TMEM-018: IN VITRO MODELS OF HGSC BASED ON MURINE OVIDUCTAL EPITHELIAL ORGANOIDS
Journal Articles

Abstract AP25: INHIBITION OF HDAC ACTIVITY SELECTIVELY INHIBITS ARID1A–MUTATED OVARIAN CLEAR CELL CARCINOMA THROUGH A NOVEL P53 REGULATORY MECHANISM

Benjamin G. Bitler, Pyoung Hwa Park, Yang Hai, Katherine M. Aird, Yemin Wang, David G. Huntsman, Kathleen R. Cho, David W. Christianson, Rugang Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): AP25.
https://doi.org/10.1158/1557-3265.OVCASYMP16-AP25
Published: 31 May 2017
View articletitled, Abstract AP25: INHIBITION OF HDAC ACTIVITY SELECTIVELY INHIBITS ARID1A–MUTATED OVARIAN CLEAR CELL CARCINOMA THROUGH A NOVEL P53 REGULATORY MECHANISM
Journal Articles

Abstract IA01: The origins of ovarian cancer.

Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): IA01.
https://doi.org/10.1158/1557-3265.OVCA15-IA01
Published: 15 January 2016
View articletitled, Abstract IA01: The origins of ovarian cancer.
Journal Articles

Abstract AS06: Development and characterization of an oviduct-specific model of high-grade serous carcinoma

Yali Zhai, Rong Wu, Tom C. Hu, Eric R. Fearon, Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): AS06.
https://doi.org/10.1158/1557-3265.OVCASYMP14-AS06
Published: 15 August 2015
View articletitled, Abstract AS06: Development and characterization of an oviduct-specific model of high-grade serous carcinoma
Journal Articles

Abstract IA6: Murine models of nonserous ovarian cancer: Effects of mutant Trp53, Pik3ca, and Arida1a in a model of endometrioid carcinoma based on Wnt and PI3K/Akt pathway defects

Kathleen R. Cho, Rong Wu, Yali Zhai, Isao Sakaguchi
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): IA6.
https://doi.org/10.1158/1078-0432.OVCA13-IA6
Published: 13 May 2014
View articletitled, Abstract IA6: Murine models of nonserous ovarian cancer: Effects of mutant Trp53, Pik3ca, and Arida1a in a model of endometrioid carcinoma based on Wnt and PI3K/Akt pathway defects
Journal Articles

Molecular Imaging Reveals a Role for AKT in Resistance to Cisplatin for Ovarian Endometrioid Adenocarcinoma

Hanxiao Wang, Stefanie Galbán, Rong Wu, Brittany M. Bowman, Amanda Witte, Katrin Vetter, Craig J. Galbán, Brian D. Ross, Kathleen R. Cho, Alnawaz Rehemtulla
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (1): 158–169.
https://doi.org/10.1158/1078-0432.CCR-12-2380
Published: 02 January 2013
View articletitled, Molecular Imaging Reveals a Role for AKT in Resistance to Cisplatin for Ovarian Endometrioid Adenocarcinoma
Open the PDF for Molecular Imaging Reveals a Role for AKT in Resistance to Cisplatin for Ovarian Endometrioid Adenocarcinoma in another window
Journal Articles

Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma

Rong Wu, Tom C. Hu, Alnawaz Rehemtulla, Eric R. Fearon, Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7359–7372.
https://doi.org/10.1158/1078-0432.CCR-11-1388
Published: 30 November 2011
View articletitled, Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma
Open the PDF for Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Histologic Type, Organ of Origin, and Wnt Pathway Status: Effect on Gene Expression in Ovarian and Uterine Carcinomas

Kerby A. Shedden, Malti P. Kshirsagar, Donald R. Schwartz, Rong Wu, Hongfeng Yu, David E. Misek, Samir Hanash, Hidetaka Katabuchi, Lora Hedrick Ellenson, Eric R. Fearon, Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (6): 2123–2131.
https://doi.org/10.1158/1078-0432.CCR-04-2061
Published: 23 March 2005
View articletitled, Histologic Type, Organ of Origin, and Wnt Pathway Status: Effect on Gene Expression in Ovarian and Uterine Carcinomas
Open the PDF for Histologic Type, Organ of Origin, and Wnt Pathway Status: Effect on Gene Expression in Ovarian and Uterine Carcinomas in another window
Journal Articles

Tight Junction Proteins Claudin-3 and Claudin-4 Are Frequently Overexpressed in Ovarian Cancer but Not in Ovarian Cystadenomas

Leticia B. A. Rangel, Rachana Agarwal, Theresa D’Souza, Ellen S. Pizer, Piero L. Alò, Wayne D. Lancaster, Lucie Gregoire, Donald R. Schwartz, Kathleen R. Cho, Patrice J. Morin
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (7): 2567–2575.
Published: 01 July 2003
View articletitled, Tight Junction Proteins Claudin-3 and Claudin-4 Are Frequently Overexpressed in Ovarian Cancer but Not in Ovarian Cystadenomas
Open the PDF for Tight Junction Proteins Claudin-3 and Claudin-4 Are Frequently Overexpressed in Ovarian Cancer but Not in Ovarian Cystadenomas in another window
Journal Articles

Loss of Fhit Expression in Invasive Cervical Carcinomas and Intraepithelial Lesions Associated with Invasive Disease

Denise C. Connolly, David L. Greenspan, Rong Wu, Xiaodan Ren, Rodney L. Dunn, Keerti V. Shah, Ronald W. Jones, F. Xavier Bosch, Nubia Muñoz, Kathleen R. Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (9): 3505–3510.
Published: 01 September 2000
View articletitled, Loss of Fhit Expression in Invasive Cervical Carcinomas and Intraepithelial Lesions Associated with Invasive Disease
Open the PDF for Loss of Fhit Expression in Invasive Cervical Carcinomas and Intraepithelial Lesions Associated with Invasive Disease in another window